PHARMACEUTICALS PRODUCT (NASDAQ:PPDI)

WEB NEWS

Friday, January 16, 2009

Comments & Business Outlook

Guidance Update: (Non-China)

2009 Guidance:

Net revenue* Guidance Range   Target Revenue Growth Rate
     
Development                      $1,530 to $1,605 Billion     10%
Discovery Sciences        $65 Million  
Total company $1,595 to $1,670  Billion 12%

EPS   Guidance Range   Target Growth Rate
     
Development                      $1.75 to $1.83 per share 10%
Discovery Sciences        $0.22 per share  
Total company $1.97 to $2.05 per share 18%


*Net revenue excludes reimbursed out-of-pocket expenses.

“We believe PPD is well-positioned to deliver solid financial results in 2009,” said Fred Eshelman, chief executive officer of PPD. “Our 2009 financial guidance demonstrates our confidence in the core development business, and we plan to continue to focus our efforts on sales execution and operational excellence throughout the year.”

 Source: Business Wire (January 14, 2009)



Market Data powered by QuoteMedia. Terms of Use